CD4 and neoplasm: Reduced the expression of MDSCs and the level of ROS, as well as the expression of MDSCs-related genes of Arg1, iNOS, S100A8, and S100A9. Enhanced INF-γ production by immune splenocytes and enhanced the proportion of anti-tumor CD8+ and CD4+ T cells